Ver mas grande
ADAM17-Specific antibody
FT-FNab00139
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB |
| Target | ADAM17 |
| Research Area | Signal Transduction, Metabolism, Cardiovascular, Immunology, Developmental biology, Neuroscience |
| Form | liquid |
| Recomended Dilution | WB: 1:200-1:2000 |
| Type Clonality | polyclonal |
| Immunogen | ADAM metallopeptidase domain 17 |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Disintegrin and metalloproteinase domain-containing protein 17 (ADAM 17)|Snake venom-like protease|TNF-alpha convertase|TNF-alpha-converting enzyme|ADAM17|CSVP|TACE |
| Host | Rabbit |
| UniProt ID | P78536 |
| Gene ID | 6868 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human |
| Observed MW | 29 kDa |
| Background | The ADAMs(A Disintegrin And Metalloprotease) are multidomain transmembrane proteins. One of the first ADAMs implicated in membrane shedding is ADAM-17, which is shown to release the active form of tumor necrosis factor(TNF)-a from its precursor(PMID:18238 |
Más información
ADAM17-Specific antibody